{"id":"NCT01535599","sponsor":"Alcon Research","briefTitle":"Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa","officialTitle":"Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2013-05","completion":"2013-05","firstPosted":"2012-02-20","resultsPosted":"2014-06-18","lastUpdate":"2014-07-08"},"enrollment":768,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Otitis Externa"],"interventions":[{"type":"DRUG","name":"AL-60371, 0.3% Otic Suspension","otherNames":[]},{"type":"OTHER","name":"AL-60371 Vehicle","otherNames":[]}],"arms":[{"label":"AL-60371","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to demonstrate the superiority of AL-60371, 0.3% Otic Suspension relative to AL-60371 Vehicle based on clinical cures at test-of-cure (TOC) for the treatment of acute otitis externa (AOE).","primaryOutcome":{"measure":"Proportion of Patients With Clinical Cures at the Day 11 (TOC) Visit","timeFrame":"Day 11","effectByArm":[{"arm":"AL-60371","deltaMin":71.7,"sd":null},{"arm":"Vehicle","deltaMin":33.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":344},"commonTop":[]}}